Back

Trastuzumab-induced cardiotoxicity: predictors and clinical outcomes

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Topical phenotypic insights in heart failure Cardiotoxicity of Drugs and Other Therapies Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Beatriz Andrade

District Hospital of Santarem, Santarem (Portugal)

6 More presentations in this session

Presentation thumbnail
Sex and atrial fibrillation identify distinct structural and clinical phenotypes in heart failure with preserved ejection fraction
Assistant Professor D. Hadareanu (Craiova, RO)
Abstract Slides
Presentation thumbnail
Differences between men and women in guideline-directed medical therapy implementation, tolerability, and outcomes in HFrEF.
Mrs M. Wilde (Rotterdam, NL) Professor J. Brugts (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Sex-specific differences in vascular function in heart failure: a systematic review
Doctor S. Younas (Coventry, GB)
Abstract Slides
Presentation thumbnail
Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk
Doctor F. Soltani (Manchester, GB)
Abstract Slides
Presentation thumbnail
Persistent and progressive dysfunction of mitochondria following brief episodes of hypoxia in dogs with chronic heart failure
Professor H. Sabbah (Detroit, US)
Abstract Slides

Access the full session

Session thumbnail
Topical phenotypic insights in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Session
Rare causes of heart failure
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources